Growth Metrics

Trevi Therapeutics (TRVI) Debt Ratio (2020 - 2023)

Trevi Therapeutics' quarterly Debt Ratio came in at 0.06 in Q1 2023, down 86.08% year-on-year from 0.46 in Q1 2022, and down 13.45% quarter-over-quarter from 0.07 in Q4 2022.

Trevi Therapeutics has reported Debt Ratio for 4 years, with the latest figure at 0.06 in Q1 2023.

  • For the quarter ending Q1 2023, Debt Ratio fell 86.08% year-over-year to 0.06; the trailing twelve-month figure through Mar 2023 stood at 0.06 (down 86.08% YoY), and the FY2022 full-year result was 0.07, down 80.24% from the prior year.
  • Debt Ratio for Q1 2023 stood at 0.06, down from 0.07 in the prior quarter.
  • The five-year high for Debt Ratio was 0.46 in Q1 2022, with the low at 0.06 in Q1 2023.
  • Average Debt Ratio over 4 years is 0.26, with a median of 0.3 recorded in 2020.
  • Year-over-year, Debt Ratio jumped 83.65% in 2021 and sank 86.08% in 2023.
  • Tracing TRVI's Debt Ratio over 4 years: stood at 0.3 in 2020, then increased by 27.16% to 0.38 in 2021, then slumped by 80.24% to 0.07 in 2022, then declined by 13.45% to 0.06 in 2023.
  • The last three Debt Ratio figures came in at 0.06 (Q1 2023), 0.07 (Q4 2022), and 0.08 (Q3 2022), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 0.18
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - 1.41
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 0.05
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -
10 Trevi Therapeutics 2.02 Bn 1.85 Bn - -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2023 0.06
Dec 31, 2022 0.07
Sep 30, 2022 0.08
Jun 30, 2022 0.15
Mar 31, 2022 0.46
Dec 31, 2021 0.38
Sep 30, 2021 0.45
Jun 30, 2021 0.36
Mar 31, 2021 0.33
Dec 31, 2020 0.30
Sep 30, 2020 0.25